Kevin Robinson


GLPs and the Importance of Standard Operating Procedures

Good laboratory practice is the central dogma of all laboratory research and investigation - it's your commitment to regulators - and poor laboratory controls are a common cause of 483 observations and preapproval inspection failures.

Market Views: A Rocky Road for Generics

by Kevin Robinson For "me too" manufacturers, the growth opportunity is in Europe ? and in biogenerics.

European Editor's Report ? An Industry Comes of Age

by Kevin Robinson, BioPharm International As we approach the end of 2002, biotechnology companies continue to be the standard bearers for innovation in the pharmaceutical industry.